The mission of the BTTC is to develop and perform hypothesis-based, state-of-the-art clinical trials in a collaborative and collegial environment emphasizing innovation and meticulous attention to protocol compliance and data quality. Through these efforts, the BTTC will strive to advance treatments for patients with neuro-oncologic illness with recognition of the importance of merging good scientific method with concern for patient well-being and outcome.